34
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Epidemiology of Methicillin-Resistant Staphylococcus aureus in Slovakia, 2020 – Emergence of an Epidemic USA300 Clone in Community and Hospitals

      research-article
      a , , b , a , c , d , a , a
      (ad hoc peer reviewer)
      Microbiology Spectrum
      American Society for Microbiology
      MRSA, PVL, USA300, Slovakia, CA-MRSA, spa typing

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          ABSTRACT

          Methicillin-resistant Staphylococcus aureus (MRSA) is a leading cause of health care-associated infections. Additionally, over the decades, the spread of community-associated (CA-MRSA) clones has become a serious problem. The aim of this study was to gain data on the current epidemiology of MRSA in Slovakia. Between January 2020 and March 2020, single-patient MRSA isolates (invasive and/or colonizing) were collected in Slovakia from hospitalized inpatients (16 hospitals) or outpatients (77 cities). Isolates were characterized via antimicrobial susceptibility testing, spa typing, SCC mec typing, the detection of mecA/ mecC, genes coding for Panton-Valentine leukocidin (PVL), and the arcA gene (part of the arginine catabolic mobile element [ACME]). Out of 412 isolates, 167 and 245 originated from hospitalized patients and outpatients, respectively. Inpatients were most likely older ( P < 0.001) and carried a strain exhibiting multiple resistance ( P = 0.015). Isolates were frequently resistant to erythromycin ( n = 320), clindamycin ( n = 268), and ciprofloxacin/norfloxacin ( n = 261). 55 isolates were resistant to oxacillin/cefoxitin only. By clonal structure, CC5-MRSA-II ( n = 106; spa types t003, t014), CC22-MRSA-IV ( n = 75; t032), and CC8-MRSA-IV ( n = 65; t008) were the most frequent. We identified PVL in 72 isolates (17.48%; 17/412), with the majority belonging to CC8-MRSA-IV ( n = 55; arcA+; t008, t622; the USA300 CA-MRSA clone) and CC5-MRSA-IV ( n = 13; t311, t323). To the best of our knowledge, this is the first study on the epidemiology of MRSA in Slovakia. The presence of the epidemic HA-MRSA clones CC5-MRSA-II and CC22-MRSA-IV was found, as was, importantly, the emergence of the global epidemic USA300 CA-MRSA clone. The extensive spread of USA300 among inpatients and outpatients across the Slovakian regions warrants further investigation.

          IMPORTANCE The epidemiology of MRSA is characterized by the rise and fall of epidemic clones. Understanding the spread, as well as the evolution of successful MRSA clones, depends on the knowledge of global MRSA epidemiology. However, basic knowledge about MRSA epidemiology is still fragmented or completely missing in some parts of the world. This is the first study of MRSA epidemiology in Slovakia to identify the presence of the epidemic HA-MRSA clones CC5-MRSA-II and CC22-MRSA-IV and, importantly and unexpectedly, the emergence of the global epidemic USA300 CA-MRSA clone in the Slovakian community and hospitals. So far, USA300 has failed to spread in Europe, and this study documents an extensive spread of this epidemic clone in a European country for the first time.

          Related collections

          Most cited references35

          • Record: found
          • Abstract: found
          • Article: not found

          Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance.

          Many different definitions for multidrug-resistant (MDR), extensively drug-resistant (XDR) and pandrug-resistant (PDR) bacteria are being used in the medical literature to characterize the different patterns of resistance found in healthcare-associated, antimicrobial-resistant bacteria. A group of international experts came together through a joint initiative by the European Centre for Disease Prevention and Control (ECDC) and the Centers for Disease Control and Prevention (CDC), to create a standardized international terminology with which to describe acquired resistance profiles in Staphylococcus aureus, Enterococcus spp., Enterobacteriaceae (other than Salmonella and Shigella), Pseudomonas aeruginosa and Acinetobacter spp., all bacteria often responsible for healthcare-associated infections and prone to multidrug resistance. Epidemiologically significant antimicrobial categories were constructed for each bacterium. Lists of antimicrobial categories proposed for antimicrobial susceptibility testing were created using documents and breakpoints from the Clinical Laboratory Standards Institute (CLSI), the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and the United States Food and Drug Administration (FDA). MDR was defined as acquired non-susceptibility to at least one agent in three or more antimicrobial categories, XDR was defined as non-susceptibility to at least one agent in all but two or fewer antimicrobial categories (i.e. bacterial isolates remain susceptible to only one or two categories) and PDR was defined as non-susceptibility to all agents in all antimicrobial categories. To ensure correct application of these definitions, bacterial isolates should be tested against all or nearly all of the antimicrobial agents within the antimicrobial categories and selective reporting and suppression of results should be avoided. © 2011 European Society of Clinical Microbiology and Infectious Diseases. No claim to original US government works.
            • Record: found
            • Abstract: found
            • Article: not found

            Waves of resistance: Staphylococcus aureus in the antibiotic era.

            Staphylococcus aureus is notorious for its ability to become resistant to antibiotics. Infections that are caused by antibiotic-resistant strains often occur in epidemic waves that are initiated by one or a few successful clones. Methicillin-resistant S. aureus (MRSA) features prominently in these epidemics. Historically associated with hospitals and other health care settings, MRSA has now emerged as a widespread cause of community infections. Community or community-associated MRSA (CA-MRSA) can spread rapidly among healthy individuals. Outbreaks of CA-MRSA infections have been reported worldwide, and CA-MRSA strains are now epidemic in the United States. Here, we review the molecular epidemiology of the epidemic waves of penicillin- and methicillin-resistant strains of S. aureus that have occurred since 1940, with a focus on the clinical and molecular epidemiology of CA-MRSA.
              • Record: found
              • Abstract: found
              • Article: not found

              Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic.

              Staphylococcus aureus is an important cause of skin and soft-tissue infections (SSTIs), endovascular infections, pneumonia, septic arthritis, endocarditis, osteomyelitis, foreign-body infections, and sepsis. Methicillin-resistant S. aureus (MRSA) isolates were once confined largely to hospitals, other health care environments, and patients frequenting these facilities. Since the mid-1990s, however, there has been an explosion in the number of MRSA infections reported in populations lacking risk factors for exposure to the health care system. This increase in the incidence of MRSA infection has been associated with the recognition of new MRSA clones known as community-associated MRSA (CA-MRSA). CA-MRSA strains differ from the older, health care-associated MRSA strains; they infect a different group of patients, they cause different clinical syndromes, they differ in antimicrobial susceptibility patterns, they spread rapidly among healthy people in the community, and they frequently cause infections in health care environments as well. This review details what is known about the epidemiology of CA-MRSA strains and the clinical spectrum of infectious syndromes associated with them that ranges from a commensal state to severe, overwhelming infection. It also addresses the therapy of these infections and strategies for their prevention.

                Author and article information

                Contributors
                Role: Editor
                Role: ad hoc peer reviewer
                Journal
                Microbiol Spectr
                Microbiol Spectr
                spectrum
                Microbiology Spectrum
                American Society for Microbiology (1752 N St., N.W., Washington, DC )
                2165-0497
                21 June 2023
                Jul-Aug 2023
                21 June 2023
                : 11
                : 4
                : e01264-23
                Affiliations
                [a ] Department of Medical Microbiology, Charles University, 2nd Faculty of Medicine and Motol University Hospital, Prague, Czech Republic
                [b ] Department of Computer Science, Czech Technical University, Faculty of Electrical Engineering, Prague, Czech Republic
                [c ] Department of Clinical Biochemistry, Haematology and Microbiology, Unilabs Slovensko, s.r.o., Roznava, Slovakia
                [d ] Department of Clinical Microbiology, Unilabs Slovensko, s.r.o., Stropkov, Slovakia
                University of Calgary
                Universitat zu Lubeck
                Author notes

                The authors declare a conflict of interest. Pavel Drevinek received research funding from the Ministry of Health, Czech Republic, consultation fees and honoraria for lectures from Vertex Pharmaceuticals and Viatris, support for attending meetings from I.T.A. Interact s.r.o., Chiesi CZ. Pavel Drevinek is also president of the Czech Society for Medical Microbiology and the board member of the European Cystic Fibrosis Society. The sponsoring institutions had no role in the study design, data collection, analysis, and interpretation of data as well as in the writing of the manuscript. The remaining authors declare that they have no conflicts of interest.

                Author information
                https://orcid.org/0000-0002-0892-924X
                https://orcid.org/0000-0002-8994-5240
                https://orcid.org/0000-0002-4511-9430
                https://orcid.org/0000-0002-1278-5939
                Article
                01264-23 spectrum.01264-23
                10.1128/spectrum.01264-23
                10433824
                37341582
                ff4fbec7-e225-40e6-962e-074572a5bd6f
                Copyright © 2023 Tkadlec et al.

                This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.

                History
                : 23 March 2023
                : 1 June 2023
                Page count
                supplementary-material: 0, Figures: 2, Tables: 2, Equations: 0, References: 35, Pages: 9, Words: 5468
                Funding
                Funded by: European Union NextGenerationEU;
                Award ID: National Institute for Virology and Bacteriology (Program Exceles ID Project No. LX22NPO5103)
                Award Recipient :
                Categories
                Research Article
                open-peer-review, Open Peer Review
                epidemiology, Epidemiology
                Custom metadata
                July/August 2023

                mrsa,pvl,usa300,slovakia,ca-mrsa,spa typing
                mrsa, pvl, usa300, slovakia, ca-mrsa, spa typing

                Comments

                Comment on this article

                Related Documents Log